mortality/aging
|
• mice have reduced life spans compared to Kras or Trp53 heterozygous mice, or Trp53 homozygotes
|
neoplasm
|
• double mutants display more malignant features than Kras heterozygous tumors, with marked cellular pleomorphism and anaplastic changes with giant cell formation
• mice have broader tumor spectrum compared to Kras or Trp53 heterozygotes, including histocytic sarcoma, medulloblastoma, osteosarcoma, and teratoma
|
|
• Background Sensitivity: about 40% of animals develop thymic lymphoma; incidence is higher than on pure 129/Sv background
|
|
• about 40% of mice develop skin papillomas, with slightly higher incidence than on mixed 129 and C57BL/6 background
|
|
• about 30% of double mutants develop fibrosarcoma
|
|
• about 30% of double mutants develop hemangiosarcoma
|
integument
|
• about 40% of mice develop skin papillomas, with slightly higher incidence than on mixed 129 and C57BL/6 background
|
endocrine/exocrine glands
|
• Background Sensitivity: about 40% of animals develop thymic lymphoma; incidence is higher than on pure 129/Sv background
|
hematopoietic system
|
• Background Sensitivity: about 40% of animals develop thymic lymphoma; incidence is higher than on pure 129/Sv background
|
immune system
|
• Background Sensitivity: about 40% of animals develop thymic lymphoma; incidence is higher than on pure 129/Sv background
|


Analysis Tools